Skip to main content

My account

Boston Scientific accounts are for healthcare professionals only.

Create an account to access online training and education on EDUCARE, manage your customer profile, and connect with customer support and service teams.

My Boston Scientific account

Access your online applications and manage your customer profile.

Manage my Boston Scientific account

Quick Links

Contact a representative
Online education and training
Order products online
Reimbursement resources
Return a product
Customer support

Call customer care

1 (888) 272-1001

Two surgeons in protective gowns and masks preparing for a benign prostatic hyperplasia (BPH) procedure in the operating room.

Benign prostatic hyperplasia (BPH)

With a proven portfolio of treatment options designed to support a range of treatment goals, Boston Scientific provides physicians with innovative and versatile options to deliver lasting relief to their patients.

Contact us

Treatment options for BPH

Surgical team in masks and gowns performing a procedure for benign prostatic hyperplasia (BPH).

Rezūm™ Water Vapor Therapy

Rezūm Therapy is a minimally invasive BPH treatment that can provide urologists with an efficient, durable treatment option that reduces prostate volume while preserving sexual function. Patients of this first-line treatment alternative experience durable lower urinary tract symptoms (LUTS) relief out to 5 years.1 Rezūm Therapy is a procedure that can be done in office, under local anesthesia or conscious sedation.

Provide your patients with lasting relief, so they can Rezūm living.

Learn more about Rezūm Therapy
Physician consulting with patients about non-surgical treatment options for benign prostatic hyperplasia (BPH).

GreenLight XPS™ Laser Therapy System

With 93% patient satisfaction and lasting outcomes for BPH patients, GreenLight Laser Therapy has:

  • Similar clinical outcomes to transurethral resection of the prostate (TURP)2
  • Shorter hospitalization times compared to TURP3
  • Shorter catheterization compared to TURP3
Learn more about GreenLight XPS Therapy

Lumenis Pulse™ 120H Holmium Laser System

The Lumenis Pulse 120H Holmium Laser System is a groundbreaking, patent-protected pulse delivery technology that has been demonstrated to result in significantly shorter treatment time due to improved enucleation efficiency and hemostasis, resulting in over 90% of patients being discharged on the same day compared to the standard holmium pulse.4,5

Compared to TURP for BPH, HoLEP has been shown to offer better 12-month functional outcomes in Qmax, PVR, and IPSS among patients with small-to-mid-sized prostates. HoLEP also demonstrated better outcomes with regard to hemoglobin loss, bladder irrigation, catheterization time, hospital stay, and blood transfusion, compared to TURP.6

Learn more about Lumenis Pulse 120H Holmium Laser System

BPH support at Boston Scientific

Clinical investment

Boston Scientific supports evidence-based innovation throughout the urological field.

Rezūm’s 5-year clinical trial, conducted by Kevin McVary, M.D., and Claus Roehrborn, M.D., was published in the Journal of Urology in September 2021. It was a multicenter, randomized, sham-controlled trial of Rezūm Water Vapor Therapy in men with moderate-to-severe LUTS due to benign prostatic hyperplasia (BPH), with the inclusion of the final surgical and BPH medication retreatment rates.

Read the Rezūm study

The GOLIATH Study was the first head-to-head trial to compare the safety and efficacy of the GreenLight XPS 180 W Laser Therapy System with transurethral resection of the prostate (TURP). It was conducted as a prospective, randomized, multicenter study in nine European countries. A total of 291 patients from 29 sites were enrolled between April 2011 and September 2012.

Read the GOLIATH study

Physician education and training

Access customizable medical education and training events designed for health care professionals through EDUCARE.

Explore EDUCARE
Two physicians talking.

Benign prostatic hyperplasia products

With in-office and surgical options, Boston Scientific helps you treat the right patients at the right time with the right option for them.

Explore products

Why choose Boston Scientific 

Physician-driven, patient-centered innovation

Whether you need more information about our benign prostatic hyperplasia or other urology products, access to education programs, or have a question about reimbursement, we can help. 

Request a rep
Boston Scientific professional with 2 physicians.

Important safety information

Rezūm Therapy Indications, Warnings, and Safety

Greenlight XPS Indications, Warnings, and Safety

Lumenis Pulse 120H Holmium Laser System Indications, Warnings, and Safety

Visible and invisible laser radiation image.

References

  1. McVary KT, El-Arabi A, Roehrborn C. Preservation of Sexual Function 5 Years After Water Vapor Thermal Therapy for Benign Prostatic Hyperplasia. Sex Med. 2021 Dec;9(6):100454. 
  2. Bachmann A, Tubaro A, Barber N, et al. 180‐WXPS GreenLight laser vaporization versus transurethral resection of the prostate for the treatment of benign prostatic obstruction: 6‐month safety and efficacy results of a European multicentre randomized trial—The GOLIATH Study. Eur Urol. 2014;65:931–942. 
  3. Capitán C, Blázquez C, Martin MD, Hernández V, de la Peña E, Llorente C. GreenLight HPS 120‐W laser vaporization versus transurethral resection of the prostate for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia: A randomized clinical trial with 2‐year follow‐up. Eur Urol. 2011;60:734–739. 
  4. Large T, Nottingham C, Stoughton C, Williams Jr J, Krambeck A. Comparative study of holmium laser enucleation of the prostate with MOSES enabled pulsed laser modulation. Urology. 2020;136:196–201. 
  5. Kavoussi NL, Nimmagadda N, Robles J, et al. MOSES technology for holmium laser enucleation of the prostate: A prospective double-blind randomized control trial. J Urol. 2021 Jul;206(1):104–8.
  6. Zhong J, Feng Z, Peng Y, et al. A systematic review and meta-analysis of efficacy and safety following holmium laser enucleation of prostate and transurethral resection of prostate for benign prostatic hyperplasia. Urology. 2019 Sep;131:14–20.

Caution: U.S. Federal law restricts this device to sale by or on the order of a physician.

All trademarks are the property of their respective owners. All images are the property of Boston Scientific.